Invesco Ltd. - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 64 filers reported holding DESIGN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$168,000
+18.3%
10,058
-0.8%
0.00%
Q2 2022$142,000
-31.1%
10,137
+5.4%
0.00%
Q4 2021$206,0009,6220.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders